Skip to content

TTPHIL ALL TILT, a new effective dental implant placement technique, for replacing teeth in patients with missing teeth

A Prospective clinical and radiographic evaluation of TTPHIL ALL TILT treatment protocol using Bioline I implant system for partially and completely edentulous maxilla and mandible - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075449
Enrollment
30
Registered
2024-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K082- Atrophy of edentulous alveolar ridge Health Condition 2: K081- Complete loss of teeth

Interventions

Intervention1: TTPHIL-ALL-TILT ® treatment protocol: TTPHIL: ALL TILT technique stands for Tall, Tilted, Pin Hole, Immediate Loading protocol, which will be utilized for implant placement and restorat

Sponsors

Dr Venkat Ratna Nag P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All cases of complete edentulism, even in resorbed maxilla and mandible. For the mandible, residual ridge crest of at least 4 mm width buccolingually and greater than 8 mm height; for the maxilla, residual ridge crest with enough width to insert a 3.5 mm–diameter implant, and greater than 8 mm height will be included in the study. 2. Immediate and delayed loading cases 3. Patients, in whom grafting procedures or zygomatic implants would be morbid or medical conditions wherein such invasive surgical procedures are contraindicated can undergo TTPHIL-ALL TILT® protocol.

Exclusion criteria

Exclusion criteria: 1. Severely debilitating systemic disease. 2. Patients undergoing chemotherapy and radiotherapy. 3. Restricted mouth opening of the patient such that access of posterior regions of maxillary and mandibular arches are compromised. Evaluation appointments will be performed at 6 months; 1 year; and 2 years for assessing implant survival. The primary outcome measure was implant and prosthesis survival based on function up to 2 years. The secondary outcome measures included marginal bone level evaluation and the incidence of biological and esthetic complications up to 2 years of function.

Design outcomes

Primary

MeasureTime frame
An implant will be considered successful (100% survival rate) if fulfilled function of supporting full-arch restoration, stable when tested clinically, no radiolucency on radiographs, and no peri-implant inflammation or suppuration. Therefore, the implant survival rate will be determined based on Malo’s criteria. Prosthetic success: A prosthesis was considered a failure if function was compromised for any reason. Fracture of the implant or any prosthetic component will be recorded, as will be technical complications with the abutments or other prosthetic components up to 2 years of function. Timepoint: 10 days; 2, 4,and 6 months; 1 year; and every 6 months

Secondary

MeasureTime frame
The secondary outcome measures included marginal bone level evaluation and soft tissue assessment at 6 months, 1 and 2 years of function. Biological complications: Peri-implantitis, peri-implant mucositis, fistula, bleeding on probing, suppuration, and numbness of the lower lip or chin will be evaluated. Esthetic complications: esthetic complaints of patients Marginal bone level evaluation: CBCT Scans will be performed with standardized scanning parameters at 90 kV, 10 mA, and using a field of view of 11cm × 8 cm.Timepoint: 6 months, 1 and 2 years of function.

Countries

India

Contacts

Public ContactDr Venkat Ratna Nag P

PhD Guide, Meenakshi Academy of Higher Education and Research

manikandhan902@gmail.com9963511139

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026